Hi, my name is Allison Schaaf, my own fertility journey, including 5 miscarriages, inspired me to create this website to help YOU navigate your own fertility journey.
Here are my main takeaways I would share with you as a friend:
- Endometriosis is underdiagnosed and often overlooked
- While endometriosis is associated with infertility and miscarriage, women with endometriosis can conceive naturally
- There are specific treatment options that can improve endometriosis and reduce the risk of miscarriage
Of course, I also recommend you do your own research! That is why I have coordinated these articles with the nitty-gritty details and links to research so you can best decide what works best for you, read on for more! And don’t miss my Action Steps at the bottom of the article!
Table of Contents
What is endometriosis?
Symptoms of endometriosis
Types and stages of endometriosis
What causes endometriosis?
How endometriosis affects pregnancy
Diagnosis of Endometriosis
Natural and experimental treatments
Endometriosis is a painful condition when your endometrial cells grow outside of the uterus. It can cause very painful periods, heavy menstrual flow, and pain during intercourse. Many women with endometriosis also struggle with infertility, pregnancy complications, and miscarriage.
Because it is under-recognized, poorly understood, and under-diagnosed, endometriosis is more prevalent than you think. It may affect up to 10% of premenopausal women and 30 – 50% of women who struggle with period symptoms, infertility, and pelvic pain 1. On average, it takes up to 6.7 years for women to be correctly diagnosed with endometriosis 2!
Although many women with endometriosis have had successful pregnancies, endometriosis does increase the risk of infertility and miscarriages 3. With this article, we hope to raise awareness, reduce diagnosis delay, and improve treatment outcomes by providing you everything you need to know about endometriosis.
What is endometriosis?
Endometriosis is an inflammatory and hormonal condition where endometrium-like tissues form lesions outside the uterus. The lesions could reside in the pelvis, around the uterus, in the Fallopian tubes, on the ovaries, and in the abdominal cavity.
Normally, the endometrial tissue or endometrium line the inside of the uterus. Naturally, these cells respond to the ebbs and flows of hormones, including estrogen and progesterone, throughout your menstrual cycles.
Endometriotic lesions may grow and shrink with each cycle, causing severe menstrual pain. Depending on their locations, the lesions may also interfere with other bodily functions and fertility. Women with endometriosis may also have progesterone resistance both in their endometrium and lesion cells, contributing to pain and fertility problems 4.
Symptoms of endometriosis
There are no specific symptoms that indicate endometriosis. It presents differently in every case, so it is underdiagnosed and often overlooked for a long time. Many women with endometriosis, as detectable by a magnetic resonance imaging (MRI) scan, have no symptoms 7. Hormonal birth control may suppress endometriosis symptoms, so you may only experience these symptoms once you are off the birth control. Also, many endometriosis symptoms are easily confused with other conditions, such as irritable bowel syndrome and pelvic inflammatory diseases.
Common endometriosis symptoms include:
- Painful period with prolonged (>7 days) and heavy menstrual bleeding
- Anemia symptoms, such as fatigue, dizziness, and heartbeat 8
- Pain during sex 9
- Chronic pelvic pain 10
- Pain or abnormal function of the bowel or bladder, including constipation or diarrhea 1112
- Abnormal bleeding, such as from the rectum
- Other discomforts in the body, depending on the location of the lesions
Types and stages of endometriosis
There are multiple ways to categorize endometriosis. One is location-based, depending on where the endometriosis lesions are found, including:
- Peritoneal superficial endometriosis is considered the least severe form of endometriosis where the lesions attach to the peritoneum. The peritoneum is the thin membrane that lines the abdomen, abdominal organs, and pelvis.
- Ovarian endometriomas are a type of endometriosis that implant on or inside the ovaries.
- Deep infiltrating endometriosis invades the organs in the abdomen or pelvic cavity, causing scar tissue or obstructing their functions. These organs may include the ovaries, Fallopian tubes, gut, bladder, or rectum.
Endometriosis staging – The American Society of Reproductive Medicine categorizes endometriosis into four stages based on the number and depths of the lesions. These include minimal (stage I), mild (stage II), moderate (stage III) and severe (stage IV). The staging should predict the chance of a successful natural pregnancy, rather the degree of pain or other symptoms. Typically, your OB/GYN determines the endometriosis stage visually during a laparoscopic diagnostic surgery. However, many other factors could determine the extent of the disease, so some gynecologists are debating a more clinically useful classification 15.
What causes endometriosis?
We still don’t completely understand what causes endometriosis. There are many hypotheses about how it occurs, but none is universally accepted. These include:
- Samson’s Retrograde Menstruation theory, which says that endometrium-like cells travel backward into the pelvic cavity 16
- Cells that are outside the womb could transform into endometrial-like cells. These cells may have the same embryonic origin as the endometrial cells itself 17
- The endometrium-like cells travel into the pelvic cavity through the lymphatic system 18
Why we still don’t understand endometriosis
Currently, laparoscopy (keyhole) surgery is the only reliable way to diagnose and stage endometriosis. It is an invasive procedure that carries the risk and cost of surgery. This makes it difficult for researchers to study endometriosis or test treatments for endometriosis. Most endometriosis clinical trials measure pain or symptoms using questionnaires rather than repeating a laparoscopy.
Decades of research have attempted to find noninvasive lab tests that can screen for endometriosis, but there hasn’t been a medical consensus 1920. Therefore, it is difficult to identify the causes and treatments for endometriosis, especially when they need a large number of women to establish a medical consensus. However, we know a few risk factors of endometriosis.
Potential causes and risk factors of endometriosis
Altered immunity – Normally, the immune system should be able to eliminate the misplaced endometrium-like cells. Endometriosis patients have less immune cells that clear out these cells 21. However, women with endometriosis are more likely to have autoimmunity, such as Lupus antibodies, thyroid antibodies, and antibodies against the endometrium 228923. They also have higher inflammatory proteins (cytokines), with a tendency towards allergic (Th2) immune response 24. Women with endometriosis are more likely to have allergic conditions, such as allergies, asthma, eczema, and hives as well.
Estrogen dominance or progesterone resistance – Endometriosis lesions outside the uterus depend on estrogen to continue to grow. These lesion cells can also convert testosterone and other forms of estrogen into the most active estrogen (estradiol) 25. Typically, progesterone opposes the growth-stimulating effects of estrogen and helps the endometrium prepare for implantation. However, in endometriosis patients, both the uterine lining and endometriosis lesions may be resistant to progesterone 2627. Because progesterone builds the uterine lining for implantation, the progesterone resistance in endometriosis can contribute to implantation failure 28.
Some modern lifestyle factors can contribute to estrogen dominance, such as toxic ingredients in personal care products and pesticides in conventional meat and produce. Also, not eating enough fiber and constipation may increase estrogen reabsorption 29.
Endocrine disruption – Many environmental toxins act like estrogen (xenoestrogens) or interfere with hormone functions, contributing to the development of endometriosis. Rhesus monkeys develop endometriosis more readily than humans. Exposing these monkeys to dioxins and polychlorinated biphenyls induced the endometriosis 3031. Studies have linked environmental toxins such as toxic metals, dioxins, benzophenones, and phthalates with endometriosis 32. These substances are often found in typical pollution exposures and common household products, such as laundry detergents, cosmetics, soap, and perfumes. However, we need more studies to confirm that these chemicals cause endometriosis in humans. For a great resource on hormone disruptor-free brands, search on the Environmental Working Group’s database.
Environmental Working Group’s Dirty Dozen List of Endocrine Disruptors
|Hormone Disruptor||Most common sources|
|Bisphenol-A (BPA)||Canned food (except BPA-free), cash receipts, polycarbonate plastic|
|Dioxin||Car exhaust and food contamination in meat, fish, and dairy products|
|Atrazine||Corn, water (contaminant)|
|Phthalates||Plastic wraps, PVC, fragrances, scented products|
|Perchlorates||Drinking water, produce, milk|
|Flame retardants||Furnitures, house dusts, carpets|
|Lead||Old paint, and water system in old houses and buildings|
|Arsenic||Rice grown in the US, water (contaminant)|
|Perfluorinated chemicals (PFC)||Teflon pans|
|Organophosphate pesticides||Non-organic produce and crops that are high in pesticides, such as berries, apples, and leafy greens. Conventional meat, fish, and poultry that are fed with sprayed crops.|
|Glycol ethers||Paint, cleaning products, brake fluids, cosmetics|
Genetics/Family history – Women with first-degree relatives with endometriosis are 5 – 7 times more likely to be diagnosed with it. Also, mothers and sisters of women with endometriosis are much more likely to have endometriosis than those of women without endometriosis. There is no “endometriosis gene,” but genes involved with detoxification, immune function, cell structure, cell overgrowth, and cell migration are linked to endometriosis 3334.
Race – Asian women are most likely to be diagnosed with endometriosis, followed by white, black, and Hispanic women. However, it is unclear whether these diagnosis rates are because the race affects their susceptibility, or if it is due to differences in healthcare seeking and access 35.
Infections – Women with endometriosis are more susceptible to genital tract infections, and the infections may trigger endometriosis. They develop endometrial inflammation due to infections (endometritis) and pelvic inflammatory diseases more readily. These women have less acidic vagina pH, which may allow bad bacteria, such as Gardnerella, Streptococcus, Enterococci, Mycoplasma, and Escherichia coli to grow and affect the endometrium 36. Also, about 11% of endometriosis lesions carry Human Papillomaviruses (HPV) 37. Typically, infections alone do not cause endometriosis, but we need more studies to determine if they are truly a trigger.
How endometriosis affects pregnancy
Endometriosis has been associated with infertility and miscarriage, although some women with endometriosis eventually conceive naturally 38. If you have minimal to mild endometriosis, you may be able to conceive without any medical or surgical intervention. More severe endometriosis, however, makes it harder to get pregnant naturally 39.
Keep in mind, however, that an endometriosis diagnosis is not all bad news. If you’ve had miscarriages and some endometriosis symptoms, it is crucial to get diagnosed and learn how it affects your body. Once you are correctly diagnosed, many treatment options can improve your chances, whether you’re trying naturally or getting fertility treatments (See Endometriosis Treatments).
- Ectopic pregnancy
- Preterm birth
- Placenta previa
- Small for gestational age infants
- Pre-eclampsia and eclampsia
- Cesarean delivery
Endometriosis and Miscarriage
Endometriosis increases the risk of miscarriage. Interestingly, based on ASRM staging, women with milder endometriosis (stages I and II) are at a higher risk of miscarriage than those with more severe forms (stages III and IV) 42.
However, classifications based on the lesion location alone, i.e., superficial peritoneal, deep infiltrating, and ovarian endometrioma may be more predictive of miscarriage risk. The superficial lesions increase the risk of miscarriage the most, followed by deep infiltrating endometriosis and ovarian endometrioma 4344.
|Endometriosis classification||Estimated miscarriage risk increase on average (%)|
|ASRM stages I – II||57%|
|ASRM stages III – IV||19%|
|Deep infiltrating endometriosis||19%|
Endometriosis may cause miscarriage by:
Interfering with the implantation process – The endometrium develops each month in response to progesterone, to prepare for implantation and pregnancy. In endometriosis patients, the endometrial tissues are less responsive to progesterone 46. Also, overall high inflammation and free radical production present in this disease disturb the fine balance necessary for implantation and placenta formation 47.
Diagnosis of Endometriosis
During this medical appointment, you bring up your endometriosis symptoms and history to your OB/GYN. These symptoms may include pelvic pain, painful menstruations (that make you skip school, painful sex, very heavy and prolonged bleeding. Difficulties in passing the stool could also be a symptom of endometriosis. Your doctor may ask clarifying questions about your symptoms, triggers, past treatments, and review your family history and medical history.
A pelvic exam can help rule out other conditions that have similar symptoms as endometriosis. This exam only lasts a few minutes. First, your OB/GYN may visually inspect your vagina and vulva. They may also insert a plastic speculum to spread open the vaginal wall. Lastly, they may also manually examine the pelvis with lubricated and gloved fingers.
An ultrasound exam is a short examination, lasting only a few minutes. It can identify gross abnormalities. It can be done across your belly (transabdominal ultrasound) or through your vagina (transvaginal ultrasound).
Transabdominal ultrasound is performed across the belly. You may be instructed to avoid eating 4-5 hours before the examination and drink a lot of water for better visualization (3-4 glasses of water every half an hour before examination). Your doctor will put the gel on the probe and scan your belly.
Transvaginal ultrasound is performed through your vagina. You should empty your bladder before the examination. Your doctor will put the condom on the probe and the gel over it, and you may feel some discomfort as the probe enters the vagina.
Magnetic resonance imaging (MRI)
An MRI is a radiologic scan used to visualize your organs and tissues with great precision. It might indicate where the endometriosis lesions are spread within the body or how to approach it surgically. The scan is not painful, you don’t need any specific preparation, and it lasts no longer than 15-30 minutes.
Currently, laparoscopy (keyhole surgery) is the only way to definitively diagnose endometriosis54. It is a minimally invasive surgery, typically performed under general anesthesia, that allows the doctor to see inside your abdomen.
Your doctor will make a tiny incision near the navel and insert an optic instrument (laparoscope), to visualize the endometrial tissue outside the uterus. Sometimes, they will also take a tissue sample (biopsy) for further analysis.
Although the surgery is minimally invasive, it requires general anesthesia, so you may be advised to avoid eating for at least 6 hours before the procedure 55. The procedure can last from half an hour to around 2 hours.
After the laparoscopy, avoid heavy physical efforts for a week. If you start feeling a fever or abdominal pain, contact your OB/GYN immediately.
Like every procedure with general anesthesia, the risks may include nausea, vomiting, after procedure pain, throat soreness, respiratory failure, cardiac failure, allergic reaction, and death (rarely). Complications are rare but may include bleeding, infection, air embolism, surgical injuries, and pulmonary embolism 56. Also, remember to notify your doctor and share your medical history, especially if you have diabetes or take blood thinners such as aspirin, heparin, or warfarin.
Your doctor may recommend over the counter pain management such as ibuprofen and naproxen sodium to relieve menstrual cramps.
Drug treatment typically does not improve fertility, either during or after treatment. Your doctor may prescribe oral contraceptives, progestins, danazol, and gonadotropin-releasing hormone agonists or antagonists (GnRH analogs). These drugs help with pain or preparation for surgery 57.
Currently, surgical removal of endometriosis implants is the only treatment that can improve fertility and relieve pain 58. In most cases, this is done in laparoscopic surgery. However, if the lesions are extensive, your physician may opt for full abdominal surgery instead.
Many women with endometriosis may consider fertility treatments to become pregnant. Also, endometriosis may affect up to half of the women seeking fertility treatments 59. Endometriosis decreases the pregnancy rate of in vitro fertilization (IVF), especially in stages III and IV, and those with affected fallopian tubes 60. Endometriosis reduces egg quality, embryo transfer, and implantation rate 61.
However, among women with endometriosis who achieve pregnancy through IVF, the miscarriage rates are comparable to those without endometriosis 626364.
Several studies have confirmed that IVF protocols do not worsen endometriosis 6566. However, it is important to work with a reproductive endocrinologist who is familiar with endometriosis. Because endometriosis is an estrogen-dominant condition, they may use a lower-estrogen protocol. They should also pay attention to your pain, symptoms, and other concerns.
Natural and experimental treatments
Currently, the standard hormonal treatments do not restore fertility, so there is a lot of interest in natural treatments and off-label use of existing drugs. The majority of these studies use pain management as the primary outcome, so we still need more studies to confirm their effects on fertility and miscarriage.
- COX-2 inhibitors. COX-2 is an enzyme that can increase inflammatory fatty acids, such as prostaglandin E2 (PGE2).
- Modulators of estrogen and progesterone function.
- Inhibitors of inflammatory proteins, such as TNF-alpha
- Diabetic drugs that activate PPAR-gamma
- Substances that inhibit the creation of new blood vessels
- Substances that inhibit aromatase enzymes, preventing the conversion of male sex hormones to produce more estrogen
- Stimulating cannabinoid receptors, such as cannabis and cannabis-like drugs 68
- Reducing oxidative stress or inhibiting inflammation by other means
Avoiding red meat – In a study involving 81,908 women and 3800 cases of endometriosis, those consuming more than 2 servings of red meat per day had 56% increased risk of endometriosis. Unprocessed red meat consumption had a stronger effect than processed red meat, but poultry, eggs, fish, and shellfish don’t have the same effects 69. Possibly, red meat may increase inflammation and estrogen in these women 70.
Gluten-free diet – In a study involving 207 women experiencing severe endometriosis symptoms on a gluten-free diet, 75% of them reported a significant reduction in pain. All patients reported improved quality of life 71.
Trans and omega-3 fats – Women who consumed more omega-3 fats were less likely to be diagnosed with endometriosis. In contrast, those who had higher trans fat intake were more likely to be diagnosed with endometriosis 72.
Low FODMAPs diet – FODMAPs stand for Fermentable Oligo-, Di-, Mono-saccharides, And Polyols, which are substances that feed your gut bacteria, such as sugar alcohol, fructose, garlic, and onions. Many people with IBS experience improvement once they avoid FODMAPs. Up to 90% of women diagnosed with endometriosis also have gastrointestinal symptoms, such as bloating, even though bowel lesions were only found in 7.6% 73. In a study involving 160 women with IBS, 36% of them also had endometriosis. Those women with endometriosis were more likely to experience >50% improvement in bowel symptoms 74.
Fruit and vegetable consumption – Fruit intake, especially citrus fruits, is associated with a lower risk of endometriosis. Whereas, the results on vegetable intake has been mixed 75.
Vegetables have a high fiber content that is good for gut health and supports estrogen metabolism which would help lower estrogen dominance.
Ketogenic diets are very low-carbohydrate and moderate protein diets, which force your body to produce ketone for energy. Anecdotally, some women with endometriosis experience significant improvement on ketogenic diets 7677. However, ketogenic diets might not be helpful for all endometriosis patients, and we need more studies to demonstrate its safety and effectiveness.
Supplements denoted with 🅧 are not considered safe for pregnancy.
Omega-3 – Omega-3 reduces COX-2 function 78. In a mouse model of endometriosis, omega-3 supplements inhibit endometriosis cells from implanting 79. A small randomized controlled trial comparing omega-3 and olive oil found some improvement in pelvic pain and well-being in both groups. Possibly, omega-3 wasn’t significantly more beneficial than olive oil because olive oil also contains antiinflammatory substances 80.
Epigallocatechin-3-gallate🅧 (EGCG) is a substance from green tea that inhibits the estrogen-stimulated growth, cell invasion, and blood vessel formation in endometriosis cells 81. However, EGCG is poorly absorbed. There is an ongoing clinical trial to study the effect of EGCG supplement on endometriosis 82 .
Combined supplement protocol – In a small clinical study involving 90 women, combined quercetin, curcumin🅧, parthenium🅧, niacinamide, 5-methyltetrahydrofolate, and omega-3/6 supplements significantly improved endometriosis symptoms, as well as inflammatory blood markers such as PGE2. 83.
N-acetylcysteine (NAC) – An Italian study compared 47 NAC-treated and 45-untreated women with endometriomas (endometriosis cysts on the ovaries) for 12 weeks. The treated group received 600 mg of NAC 3 times a day, three consecutive days a week. On average, the treated group had slightly reduced cyst size, with the cysts completely disappearing in 8 women. Whereas, in the untreated group, their cysts grew by 6.6 mm on average and disappeared in 4 of them. 23 NAC-treated patients vs 1 untreated canceled their surgery due to the reduced pain and cyst size by the end of the study period. Overall, 8 women in the treated group and 6 in the untreated group became pregnant 85.
Pycnogenol (pine bark extract)🅧 – 32 women taking 60 mg of pycnogenol were compared with 26 patients taking the drug leuprorelin acetate🅧, a standard treatment, for 48 weeks. Overall, the pycnogenol reduced the pain more slowly than the drug, but there was no rebound effect after the treatments were completed. Among the women taking pycnogenol, 5 of them became pregnant 86.
Traditional Chinese Medicine is a common treatment for endometriosis in China, although most clinical studies only involve small numbers of women 87. One study compared 40 women who took a Chinese herb formula to another 40 who took hormone therapy (mifepristone🅧). The Chinese herb group experienced comparable improvement in inflammatory markers and hormone levels compared to the hormone therapy group. Although not statistically significant, 21 women in the Chinese herb group became pregnant versus 15 in the medication group. However, the miscarriage rate was similar, with 3 miscarriages in the herb group and 2 in the medication group. In the end, 18 out of 40 women in the Chinese medicine group, compared to 13 out of 40 in the medication group, successfully delivered babies 88.
Next Steps to Consider
- If you have been diagnosed with endometriosis, discuss the above treatment options with your doctor
- If you think you might have endometriosis, find a doctor that specializes in working with women with endometriosis who can help with a diagnosis and treatment options
- Stay hopeful! Women diagnosed with endometriosis can go on to have a successful pregnancy.
|⇧1||Rogers PAW, D’Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16: 335–346. Available: https://pubmed.ncbi.nlm.nih.gov/19196878/|
|⇧2||Nnoaham KE, Hummelshoj L, Webster P, d’Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96: 366–373.e8. Available: https://pubmed.ncbi.nlm.nih.gov/21718982/|
|⇧3||Kohl Schwartz AS, Wölfler MM, Mitter V, Rauchfuss M, Haeberlin F, Eberhard M, et al. Endometriosis, especially mild disease: a risk factor for miscarriages. Fertil Steril. 2017;108: 806–814.e2. Available:https://pubmed.ncbi.nlm.nih.gov/29079275/|
|⇧4||McKinnon B, Mueller M, Montgomery G. Progesterone Resistance in Endometriosis: an Acquired Property? Trends Endocrinol Metab. 2018;29: 535–548. Available: https://pubmed.ncbi.nlm.nih.gov/29934050/|
|⇧5||What causes endometriosis? Institute for Quality and Efficiency in Health Care (IQWiG); 2017. https://www.ncbi.nlm.nih.gov/books/NBK279503/|
|⇧6||What causes endometriosis? Institute for Quality and Efficiency in Health Care (IQWiG); 2017. https://www.ncbi.nlm.nih.gov/books/NBK279503/|
|⇧7||Rogers PAW, D’Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16: 335–346. Available: https://pubmed.ncbi.nlm.nih.gov/19196878/|
|⇧8||Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20: 2698–2704. Available: https://pubmed.ncbi.nlm.nih.gov/15980014/|
|⇧9||Endometriosis – Gynecology and Obstetrics – MSD Manual Professional Edition. In: MSD Manual Professional Edition [Internet]. MSD Manuals; [cited 21 Jul 2020]. https://www.msdmanuals.com/professional/gynecology-and-obstetrics/endometriosis/endometriosis?query=endometriosis|
|⇧10||Endometriosis – Gynecology and Obstetrics – MSD Manual Professional Edition. In: MSD Manual Professional Edition [Internet]. MSD Manuals; [cited 21 Jul 2020]. https://www.msdmanuals.com/professional/gynecology-and-obstetrics/endometriosis/endometriosis?query=endometriosis|
|⇧11||Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362: 2389–2398. Available: https://pubmed.ncbi.nlm.nih.gov/20573927/|
|⇧12||Endometriosis – Symptoms and causes – Mayo Clinic. 2019 [cited 21 Jul 2020]. https://www.mayoclinic.org/diseases-conditions/endometriosis/symptoms-causes/syc-20354656|
|⇧13||Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362: 2389–2398. Available: https://pubmed.ncbi.nlm.nih.gov/20573927/|
|⇧14||Endometriosis – Symptoms and causes – Mayo Clinic. 2019 [cited 21 Jul 2020]. https://www.mayoclinic.org/diseases-conditions/endometriosis/symptoms-causes/syc-20354656|
|⇧15||Tran DK, Belaisch J, the members of the French Endometriosis Study Group (GEE). Is it time to change the ASRM classification for endometriosis lesions? Proposal for a functional FOATIaRVS classification. Gynecol Surg. 2012;9: 369–373. Available: https://link.springer.com/article/10.1007/s10397-012-0739-3|
|⇧16||Redwine DB. Was Sampson wrong? Fertil Steril. 2002;78: 686–693. Available: https://pubmed.ncbi.nlm.nih.gov/12372441/|
|⇧17||What causes endometriosis? Institute for Quality and Efficiency in Health Care (IQWiG); 2017. https://www.ncbi.nlm.nih.gov/books/NBK279503/|
|⇧18||Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98: 511–519. Available: https://pubmed.ncbi.nlm.nih.gov/22819144/|
|⇧19||May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16: 651–674. Available: https://pubmed.ncbi.nlm.nih.gov/20462942/|
|⇧20||Gupta D, Hull ML, Fraser I, Miller L, Bossuyt PMM, Johnson N, et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;4: CD012165. Available: https://pubmed.ncbi.nlm.nih.gov/27094925/|
|⇧21||Králíčková M, Vetvicka V. Immunological aspects of endometriosis: a review. Ann Transl Med. 2015;3: 153. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499658/|
|⇧22||Pasoto SG, Abrao MS, Viana VST, Bueno C, Leon EP, Bonfa E. Endometriosis and systemic lupus erythematosus: a comparative evaluation of clinical manifestations and serological autoimmune phenomena. Am J Reprod Immunol. 2005;53: 85–93. Available: https://pubmed.ncbi.nlm.nih.gov/15790342/|
|⇧23||Garza D, Mathur S, Dowd MM, Smith LF, Williamson HO. Antigenic differences between the endometrium of women with and without endometriosis. J Reprod Med. 1991;36: 177–182. https://www.ncbi.nlm.nih.gov/pubmed/2030493|
|⇧24||Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Lymphocytes in endometriosis. Am J Reprod Immunol. 2011;65: 1–10. Available: https://pubmed.ncbi.nlm.nih.gov/20584009/|
|⇧25||Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83: 149–155. Available: https://pubmed.ncbi.nlm.nih.gov/12650711/|
|⇧26||McKinnon B, Mueller M, Montgomery G. Progesterone Resistance in Endometriosis: an Acquired Property? Trends Endocrinol Metab. 2018;29: 535–548. Available: https://pubmed.ncbi.nlm.nih.gov/29934050/|
|⇧27||Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand. 2017;96: 623–632. Available: https://pubmed.ncbi.nlm.nih.gov/28423456/|
|⇧28||Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand. 2017;96: 623–632. Available: https://pubmed.ncbi.nlm.nih.gov/28423456/|
|⇧29||Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med. 1982;307: 1542–1547. Available: https://pubmed.ncbi.nlm.nih.gov/7144835/|
|⇧30||Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1993;21: 433–441. Available: https://pubmed.ncbi.nlm.nih.gov/8253297/|
|⇧31||Rier SE, Turner WE, Martin DC, Morris R, Lucier GW, Clark GC. Serum levels of TCDD and dioxin-like chemicals in Rhesus monkeys chronically exposed to dioxin: correlation of increased serum PCB levels with endometriosis. Toxicol Sci. 2001;59: 147–159. Available: https://pubmed.ncbi.nlm.nih.gov/11134554/|
|⇧32||Smarr MM, Kannan K, Buck Louis GM. Endocrine disrupting chemicals and endometriosis. Fertil Steril. 2016;106: 959–966. Available: https://pubmed.ncbi.nlm.nih.gov/27424048/|
|⇧33||Hansen KA, Eyster KM. Genetics and genomics of endometriosis. Clin Obstet Gynecol. 2010;53: 403–412. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346178/|
|⇧34||Grechukhina O, Petracco R, Popkhadze S, Massasa E, Paranjape T, Chan E, et al. A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis. EMBO Mol Med. 2012;4: 206–217. Available: https://pubmed.ncbi.nlm.nih.gov/22307873/|
|⇧35||Bougie O, Yap MI, Sikora L, Flaxman T, Singh S. Influence of race/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta-analysis. BJOG. 2019;126: 1104–1115. Available: https://pubmed.ncbi.nlm.nih.gov/30908874/|
|⇧36||Koninckx PR, Ussia A, Tahlak M, Adamyan L, Wattiez A, Martin DC, et al. Infection as a potential cofactor in the genetic-epigenetic pathophysiology of endometriosis: a systematic review. Facts Views Vis Obgyn. 2019;11: 209–216. https://www.ncbi.nlm.nih.gov/pubmed/32082526|
|⇧37||Oppelt P, Renner SP, Strick R, Valletta D, Mehlhorn G, Fasching PA, et al. Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions. Fertil Steril. 2010;93: 1778–1786. Available: https://pubmed.ncbi.nlm.nih.gov/19200955/|
|⇧38||Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012;39: 535–549. Available: https://pubmed.ncbi.nlm.nih.gov/23182559/|
|⇧39||Endometriosis, Fertility and Pregnancy. In: Endometriosis UK [Internet]. Sep 2008. https://www.endometriosis-uk.org/sites/default/files/files/Information/fertility.pdf|
|⇧40||Zullo F, Spagnolo E, Saccone G, Acunzo M, Xodo S, Ceccaroni M, et al. Endometriosis and obstetrics complications: a systematic review and meta-analysis. Fertil Steril. 2017;108: 667–672.e5. Available:https://pubmed.ncbi.nlm.nih.gov/28874260/|
|⇧41||Farland LV, Prescott J, Sasamoto N, Tobias DK, Gaskins AJ, Stuart JJ, et al. Endometriosis and Risk of Adverse Pregnancy Outcomes. Obstet Gynecol. 2019;134: 527–536. Available: https://pubmed.ncbi.nlm.nih.gov/31403584/|
|⇧42||Kohl Schwartz AS, Wölfler MM, Mitter V, Rauchfuss M, Haeberlin F, Eberhard M, et al. Endometriosis, especially mild disease: a risk factor for miscarriages. Fertil Steril. 2017;108: 806–814.e2. Available: https://pubmed.ncbi.nlm.nih.gov/29079275/|
|⇧43||Kohl Schwartz AS, Wölfler MM, Mitter V, Rauchfuss M, Haeberlin F, Eberhard M, et al. Endometriosis, especially mild disease: a risk factor for miscarriages. Fertil Steril. 2017;108: 806–814.e2. Available: https://pubmed.ncbi.nlm.nih.gov/29079275/|
|⇧44||Santulli P, Marcellin L, Menard S, Thubert T, Khoshnood B, Gayet V, et al. Increased rate of spontaneous miscarriages in endometriosis-affected women. Hum Reprod. 2016;31: 1014–1023. Available: https://pubmed.ncbi.nlm.nih.gov/26965434/|
|⇧45||Kohl Schwartz AS, Wölfler MM, Mitter V, Rauchfuss M, Haeberlin F, Eberhard M, et al. Endometriosis, especially mild disease: a risk factor for miscarriages. Fertil Steril. 2017;108: 806–814.e2. Available: https://pubmed.ncbi.nlm.nih.gov/29079275/|
|⇧46||Yang P, Wang Y, Wu Z, Pan N, Yan L, Ma C. Risk of miscarriage in women with endometriosis undergoing IVF fresh cycles: a retrospective cohort study. Reprod Biol Endocrinol. 2019;17: 21. Available: https://pubmed.ncbi.nlm.nih.gov/30755216/|
|⇧47||Leone Roberti Maggiore U, Ferrero S, Mangili G, Bergamini A, Inversetti A, Giorgione V, et al. A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update. 2016;22: 70–103. Available: https://pubmed.ncbi.nlm.nih.gov/26450609/|
|⇧48||Leone Roberti Maggiore U, Ferrero S, Mangili G, Bergamini A, Inversetti A, Giorgione V, et al. A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update. 2016;22: 70–103. Available: https://pubmed.ncbi.nlm.nih.gov/26450609/|
|⇧49||Vassilopoulou L, Matalliotakis M, Zervou MI, Matalliotaki C, Spandidos DA, Matalliotakis I, et al. Endometriosis and in vitro fertilisation. Exp Ther Med. 2018;16: 1043–1051. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090275/|
|⇧50||de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376: 730–738. Available: https://pubmed.ncbi.nlm.nih.gov/20801404/|
|⇧51||Holoch KJ, Lessey BA. Endometriosis and infertility. Clin Obstet Gynecol. 2010;53: 429–438. Available: https://pubmed.ncbi.nlm.nih.gov/20436320/|
|⇧52||Endometriosis, Fertility and Pregnancy. In: Endometriosis UK [Internet]. Sep 2008. https://www.endometriosis-uk.org/sites/default/files/files/Information/fertility.pdf|
|⇧53||Endometriosis – Diagnosis and treatment – Mayo Clinic. 2019 [cited 21 Jul 2020]. https://www.mayoclinic.org/diseases-conditions/endometriosis/diagnosis-treatment/drc-20354661|
|⇧54||Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014;348: g1752. Available: https://pubmed.ncbi.nlm.nih.gov/24647161/|
|⇧55||Website NHS. How it’s performed. 1 Aug 2018 [cited 21 Jul 2020]. https://www.nhs.uk/conditions/laparoscopy/what-happens/|
|⇧56||Website NHS. How it’s performed. 1 Aug 2018 [cited 21 Jul 2020]. https://www.nhs.uk/conditions/laparoscopy/what-happens/|
|⇧57||Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. 2010;27: 441–447. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941592/|
|⇧58||Jacobson TZ, Duffy JM, Barlow D, Farquhar C, Koninckx PR, Olive D. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev. 2010; CD001398. Available: https://pubmed.ncbi.nlm.nih.gov/20091519/|
|⇧59||Muteshi CM, Ohuma EO, Child T, Becker CM. The effect of endometriosis on live birth rate and other reproductive outcomes in ART cycles: a cohort study. Hum Reprod Open. 2018;2018: hoy016. Available: https://academic.oup.com/hropen/article/2018/4/hoy016/5110584|
|⇧60||Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference. Acta Obstet Gynecol Scand. 2011;90: 1232–1238. Available: https://pubmed.ncbi.nlm.nih.gov/21793811/|
|⇧61||Muteshi CM, Ohuma EO, Child T, Becker CM. The effect of endometriosis on live birth rate and other reproductive outcomes in ART cycles: a cohort study. Hum Reprod Open. 2018;2018: hoy016. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276688/|
|⇧62||Yang P, Wang Y, Wu Z, Pan N, Yan L, Ma C. Risk of miscarriage in women with endometriosis undergoing IVF fresh cycles: a retrospective cohort study. Reprod Biol Endocrinol. 2019;17: 21. Available: https://rbej.biomedcentral.com/articles/10.1186/s12958-019-0463-1|
|⇧63||Muteshi CM, Ohuma EO, Child T, Becker CM. The effect of endometriosis on live birth rate and other reproductive outcomes in ART cycles: a cohort study. Hum Reprod Open. 2018;2018: hoy016. Available: https://academic.oup.com/hropen/article/2018/4/hoy016/5110584|
|⇧64||Leonardi M, Papaleo E, Reschini M, Pagliardini L, Benaglia L, Candotti G, et al. Risk of miscarriage in women with endometriosis: insights from in vitro fertilization cycles. Fertil Steril. 2016;106: 386–392.e3. Available: https://moh-it.pure.elsevier.com/en/publications/risk-of-miscarriage-in-women-with-endometriosis-insights-from-in–2|
|⇧65||Benaglia L, Somigliana E, Santi G, Scarduelli C, Ragni G, Fedele L. IVF and endometriosis-related symptom progression: insights from a prospective study. Hum Reprod. 2011;26: 2368–2372. Available: https://pubmed.ncbi.nlm.nih.gov/21715451/|
|⇧66||Santulli P, Bourdon M, Presse M, Gayet V, Marcellin L, Prunet C, et al. Endometriosis-related infertility: assisted reproductive technology has no adverse impact on pain or quality-of-life scores. Fertil Steril. 2016;105: 978–987.e4. Available: https://pubmed.ncbi.nlm.nih.gov/26746132/|
|⇧67||Attar R, Attar E. Experimental treatments of endometriosis. Women’s Health. 2015;11: 653–664. Available: https://pubmed.ncbi.nlm.nih.gov/26314760/|
|⇧68||Dmitrieva N, Nagabukuro H, Resuehr D, Zhang G, McAllister SL, McGinty KA, et al. Endocannabinoid involvement in endometriosis. Pain. 2010;151: 703–710. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972363/|
|⇧69||Yamamoto A, Harris HR, Vitonis AF, Chavarro JE, Missmer SA. A prospective cohort study of meat and fish consumption and endometriosis risk. Am J Obstet Gynecol. 2018;219: 178.e1–178.e10. Available: https://pubmed.ncbi.nlm.nih.gov/29870739/|
|⇧70||Harmon BE, Morimoto Y, Beckford F, Franke AA, Stanczyk FZ, Maskarinec G. Oestrogen levels in serum and urine of premenopausal women eating low and high amounts of meat. Public Health Nutr. 2014;17: 2087–2093. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231431/|
|⇧71||Marziali M, Venza M, Lazzaro S, Lazzaro A, Micossi C, Stolfi VM. Gluten-free diet: a new strategy for management of painful endometriosis related symptoms? Minerva Chir. 2012;67: 499–504. https://www.ncbi.nlm.nih.gov/pubmed/23334113|
|⇧72||Missmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod. 2010;25: 1528–1535. Available: https://pubmed.ncbi.nlm.nih.gov/20332166/|
|⇧73||Maroun P, Cooper MJW, Reid GD, Keirse MJNC. Relevance of gastrointestinal symptoms in endometriosis. Aust N Z J Obstet Gynaecol. 2009;49: 411–414. Available: https://pubmed.ncbi.nlm.nih.gov/19694698/|
|⇧74||Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet. Aust N Z J Obstet Gynaecol. 2017;57: 201–205. Available: https://pubmed.ncbi.nlm.nih.gov/28303579/|
|⇧75||Harris HR, Eke AC, Chavarro JE, Missmer SA. Fruit and vegetable consumption and risk of endometriosis. Hum Reprod. 2018;33: 715–727. Available: https://pubmed.ncbi.nlm.nih.gov/29401293/|
|⇧76||Campbell L. Leah Campbell Could the Keto Diet Help with Endometriosis Pain? In: Healthline [Internet]. Healthline Media; [cited 21 Jul 2020]. https://www.healthline.com/health/keto-for-endometriosis|
|⇧77||NO MORE PAIN with Keto diet … – Endometriosis UK. In: HealthUnlocked [Internet]. 26 Jan 2020 [cited 21 Jul 2020]. https://healthunlocked.com/endometriosis-uk/posts/142528506/no-more-pain-with-keto-diet-the-healthy-endo-friendly-version-gluten-dairy-red-meat-free|
|⇧78||Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A. 2006;103: 15184–15189. Available: https://pubmed.ncbi.nlm.nih.gov/17018645/|
|⇧79||Herington JL, Glore DR, Lucas JA, Osteen KG, Bruner-Tran KL. Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in a chimeric mouse model. Fertil Steril. 2013;99: 543–550. Available: https://pubmed.ncbi.nlm.nih.gov/23103017/|
|⇧80||Abokhrais IM, Denison FC, Whitaker LHR, Saunders PTK, Doust A, Williams LJ, et al. A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1). PLoS One. 2020;15: e0227695. Available: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0227695|
|⇧81||Laschke MW, Schwender C, Scheuer C, Vollmar B, Menger MD. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod. 2008;23: 2308–2318. Available: https://pubmed.ncbi.nlm.nih.gov/18603648/|
|⇧82||Green Tea for Endometriosis – Full Text View – ClinicalTrials.gov. [cited 21 Jul 2020]. https://clinicaltrials.gov/ct2/show/NCT02832271|
|⇧83||Signorile PG, Viceconte R, Baldi A. Novel dietary supplement association reduces symptoms in endometriosis patients. J Cell Physiol. 2018;233: 5920–5925. Available: https://pubmed.ncbi.nlm.nih.gov/29243819/|
|⇧84||Santanam N, Kavtaradze N, Murphy A, Dominguez C, Parthasarathy S. Antioxidant supplementation reduces endometriosis-related pelvic pain in humans. Transl Res. 2013;161: 189–195. Available: https://pubmed.ncbi.nlm.nih.gov/22728166/|
|⇧85||Porpora MG, Brunelli R, Costa G, Imperiale L, Krasnowska EK, Lundeberg T, et al. A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine. Evid Based Complement Alternat Med. 2013;2013: 240702. Available: https://pubmed.ncbi.nlm.nih.gov/23737821/|
|⇧86||Kohama T, Negami M. Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial. J Reprod Med. 2013;58: 39–46. https://www.ncbi.nlm.nih.gov/pubmed/23447917|
|⇧87||Flower A, Liu JP, Lewith G, Little P, Li Q. Chinese herbal medicine for endometriosis. Cochrane Database Syst Rev. 2012; CD006568. Available: https://pubmed.ncbi.nlm.nih.gov/19588398/|
|⇧88||Ding Z, Lian F. Traditional Chinese medical herbs staged therapy in infertile women with endometriosis: a clinical study. Int J Clin Exp Med. 2015;8: 14085–14089. https://www.ncbi.nlm.nih.gov/pubmed/26550373|
|⇧89||Poppe K, Glinoer D, Van Steirteghem A, Tournaye H, Devroey P, Schiettecatte J, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid. 2002;12: 997–1001. Available: https://pubmed.ncbi.nlm.nih.gov/12490077/|